NRF2 has been reported to prevent epithelial barrier damage in various disease models, including Salmonella typhimurium infection [46], IBD [[46], [47], [48]], severe sepsis [49], and traumatic brain injury-induced intestinal mucosal damage [50]. The gene discussed is NFE2L2; the disease is inflammatory bowel disease.